Research ArticleArticle
Mechanism of the Antiproliferative Activity of Some Naphthalene Diimide G-Quadruplex Ligands
Sonja M. Hampel, Antonella Pepe, Karin M. Greulich-Bode, Sanjay V. Malhotra, Anthony P. Reszka, Sebastian Veith, Petra Boukamp and Stephen Neidle
Molecular Pharmacology February 2013, 83 (2) 470-480; DOI: https://doi.org/10.1124/mol.112.081075
Sonja M. Hampel
School of Pharmacy, University College London, London, United Kingdom (S.M.H., A.P.R., S.N.); Laboratory of Synthetic Chemistry, Developmental Therapeutics Program Support, SAIC-Frederick, Inc., Frederick National Laboratory for Cancer Research, Frederick, Maryland (A.P., S.V.M.); Genetics of Skin Carcinogenesis, German Cancer Research Center Heidelberg, Heidelberg, Germany (K.M.G.-B., P.B.); and Molecular Toxicology Group, Department of Biology, University of Konstanz, Konstanz, Germany (S.V.)
Antonella Pepe
School of Pharmacy, University College London, London, United Kingdom (S.M.H., A.P.R., S.N.); Laboratory of Synthetic Chemistry, Developmental Therapeutics Program Support, SAIC-Frederick, Inc., Frederick National Laboratory for Cancer Research, Frederick, Maryland (A.P., S.V.M.); Genetics of Skin Carcinogenesis, German Cancer Research Center Heidelberg, Heidelberg, Germany (K.M.G.-B., P.B.); and Molecular Toxicology Group, Department of Biology, University of Konstanz, Konstanz, Germany (S.V.)
Karin M. Greulich-Bode
School of Pharmacy, University College London, London, United Kingdom (S.M.H., A.P.R., S.N.); Laboratory of Synthetic Chemistry, Developmental Therapeutics Program Support, SAIC-Frederick, Inc., Frederick National Laboratory for Cancer Research, Frederick, Maryland (A.P., S.V.M.); Genetics of Skin Carcinogenesis, German Cancer Research Center Heidelberg, Heidelberg, Germany (K.M.G.-B., P.B.); and Molecular Toxicology Group, Department of Biology, University of Konstanz, Konstanz, Germany (S.V.)
Sanjay V. Malhotra
School of Pharmacy, University College London, London, United Kingdom (S.M.H., A.P.R., S.N.); Laboratory of Synthetic Chemistry, Developmental Therapeutics Program Support, SAIC-Frederick, Inc., Frederick National Laboratory for Cancer Research, Frederick, Maryland (A.P., S.V.M.); Genetics of Skin Carcinogenesis, German Cancer Research Center Heidelberg, Heidelberg, Germany (K.M.G.-B., P.B.); and Molecular Toxicology Group, Department of Biology, University of Konstanz, Konstanz, Germany (S.V.)
Anthony P. Reszka
School of Pharmacy, University College London, London, United Kingdom (S.M.H., A.P.R., S.N.); Laboratory of Synthetic Chemistry, Developmental Therapeutics Program Support, SAIC-Frederick, Inc., Frederick National Laboratory for Cancer Research, Frederick, Maryland (A.P., S.V.M.); Genetics of Skin Carcinogenesis, German Cancer Research Center Heidelberg, Heidelberg, Germany (K.M.G.-B., P.B.); and Molecular Toxicology Group, Department of Biology, University of Konstanz, Konstanz, Germany (S.V.)
Sebastian Veith
School of Pharmacy, University College London, London, United Kingdom (S.M.H., A.P.R., S.N.); Laboratory of Synthetic Chemistry, Developmental Therapeutics Program Support, SAIC-Frederick, Inc., Frederick National Laboratory for Cancer Research, Frederick, Maryland (A.P., S.V.M.); Genetics of Skin Carcinogenesis, German Cancer Research Center Heidelberg, Heidelberg, Germany (K.M.G.-B., P.B.); and Molecular Toxicology Group, Department of Biology, University of Konstanz, Konstanz, Germany (S.V.)
Petra Boukamp
School of Pharmacy, University College London, London, United Kingdom (S.M.H., A.P.R., S.N.); Laboratory of Synthetic Chemistry, Developmental Therapeutics Program Support, SAIC-Frederick, Inc., Frederick National Laboratory for Cancer Research, Frederick, Maryland (A.P., S.V.M.); Genetics of Skin Carcinogenesis, German Cancer Research Center Heidelberg, Heidelberg, Germany (K.M.G.-B., P.B.); and Molecular Toxicology Group, Department of Biology, University of Konstanz, Konstanz, Germany (S.V.)
Stephen Neidle
School of Pharmacy, University College London, London, United Kingdom (S.M.H., A.P.R., S.N.); Laboratory of Synthetic Chemistry, Developmental Therapeutics Program Support, SAIC-Frederick, Inc., Frederick National Laboratory for Cancer Research, Frederick, Maryland (A.P., S.V.M.); Genetics of Skin Carcinogenesis, German Cancer Research Center Heidelberg, Heidelberg, Germany (K.M.G.-B., P.B.); and Molecular Toxicology Group, Department of Biology, University of Konstanz, Konstanz, Germany (S.V.)
MolPharm articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|
Log in using your username and password
Purchase access
You may purchase access to this article. This will require you to create an account if you don't already have one.
In this issue
Research ArticleArticle
Mechanism of Action of G-Quadruplex Ligand
Sonja M. Hampel, Antonella Pepe, Karin M. Greulich-Bode, Sanjay V. Malhotra, Anthony P. Reszka, Sebastian Veith, Petra Boukamp and Stephen Neidle
Molecular Pharmacology February 1, 2013, 83 (2) 470-480; DOI: https://doi.org/10.1124/mol.112.081075
Research ArticleArticle
Mechanism of Action of G-Quadruplex Ligand
Sonja M. Hampel, Antonella Pepe, Karin M. Greulich-Bode, Sanjay V. Malhotra, Anthony P. Reszka, Sebastian Veith, Petra Boukamp and Stephen Neidle
Molecular Pharmacology February 1, 2013, 83 (2) 470-480; DOI: https://doi.org/10.1124/mol.112.081075
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement